Search Results - "Jacobsen, Carol A."

Efficacy and Safety of Lovastatin in Adolescent Males With Heterozygous Familial Hypercholesterolemia: A Randomized Controlled Trial by Stein, Evan A, Illingworth, D. Roger, Kwiterovich, Jr, Peter O, Liacouras, Chris A, Siimes, Martti A, Jacobson, Marc S, Brewster, Thomas G, Hopkins, Paul, Davidson, Michael, Graham, Kevin, Arensman, Frederick, Knopp, Robert H, DuJovne, Carlos, Williams, Christine L, Isaacsohn, Jonathan L, Jacobsen, Carol A, Laskarzewski, Peter M, Ames, Sharon, Gormley, Glenn J

“…CONTEXT Heterozygous familial hypercholesterolemia (HeFH) is a common disorder associated with early coronary artery disease, especially in men. The age at…”
Get full text

Synergy between fosfomycin and arenaemycin by Dulaney, E L, Jacobsen, C A

Get more information

Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men by Overstreet, J W, Fuh, V L, Gould, J, Howards, S S, Lieber, M M, Hellstrom, W, Shapiro, S, Carroll, P, Corfman, R S, Petrou, S, Lewis, R, Toth, P, Shown, T, Roy, J, Jarow, J P, Bonilla, J, Jacobsen, C A, Wang, D Z, Kaufman, K D

“…Finasteride, an oral type 2, 5alpha-reductase inhibitor, is used in 1 mg. daily doses for the treatment of male pattern hair loss. A dose of 5 mg. finasteride…”
Get more information

Synergy of patulin with other antibiotics by Dulaney, E L, Jacobsen, C A

Get more information

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years by Hudson, Perry B., Boake, Rex, Trachtenberg, John, Romas, Nicholas A., Rosenblatt, Sidney, Narayan, Perinchery, Geller, Jack, Lieber, Michael M., Elhilali, Mostafa, Norman, Richard, Patterson, Lynn, Perreault, Jean-Paul, Malek, Gholam H., Bruskewitz, Reginald C., Roy, Johnny B., Ko, Amy, Jacobsen, Carol A., Stoner, Elizabeth

“…Objectives. The purpose of this open-label study extension was to assess the long-term safety and efficacy of finasteride in the treatment of men with benign…”
Get full text

Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years by Schäfer, W., Tammela, T.L.J., Barrett, D.M., Abrams, P., Hedlund, H., Rollema, H.J., Nordling, J., Andersen, J.T., Hald, T., Matos-Ferriera, A., Bruskewitz, R., Miller, P., Mustonen, S., Cannon, A., Malice, Marie-Pierre, Jacobsen, Carol A., Bach, Mark A.

“…Objectives. To assess the long-term effects of finasteride on pressure-flow parameters in men with urodynamically documented bladder outflow obstruction (BOO)…”
Get full text